UNITED THERAPEUTICS Corp (UTHR) › Capital ExpendituresUNITED THERAPEUTICS Corp (UTHR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2008: $124.42M2009: $95.40M2010: $18.64M2011: $35.98M2012: $111.91M2013: $31.91M2014: $47.40M2015: $49.80M2016: $38.00M2017: $86.30M2018: $184.40M2019: $83.70M2020: $59.30M2021: $120.80M2022: $138.80M2023: $230.40M2024: $246.50M2025: $520.50M$520.50M2008Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$520.50M+111.2%2024$246.50M+7.0%2023$230.40M+66.0%2022$138.80M+14.9%2021$120.80M+103.7%2020$59.30M-29.2%2019$83.70M-54.6%2018$184.40M+113.7%2017$86.30M+127.1%2016$38.00M-23.7%2015$49.80M+5.1%2014$47.40M+48.5%2013$31.91M-71.5%2012$111.91M+211.0%2011$35.98M+93.0%2010$18.64M-80.5%2009$95.40M-23.3%2008$124.42M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share